48 results
Page 2 of 3
POS AM
4gnta5ep2r
30 Mar 22
Prospectus update (post-effective amendment)
7:32am
10-K
o9fp05t026uiwqhc54f
29 Mar 22
Annual report
5:29pm
8-K
EX-99.1
rhbjfmz5o85w09bm
29 Mar 22
Pardes Biosciences Reports Full Year 2021 Financial Results and Provides Business Update
4:05pm
424B3
6w6g5uq7
2 Mar 22
Prospectus supplement
4:23pm
8-K
EX-99.1
6e3k32a yv
2 Mar 22
Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board
4:16pm
8-K
EX-99.2
y76vuw5v6gmee
14 Feb 22
Regulation FD Disclosure
7:26am
424B3
ksbsju6mlpm5tq
1 Feb 22
Prospectus supplement
5:03pm
8-K
EX-99.1
qt9o7
7 Jan 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
0mgiwlq4pfw3i2xd8cs
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
8-K
3nef13m81h
30 Dec 21
Entry into a Material Definitive Agreement
4:55pm
424B3
9yq58nmt1wuar8mupp36
1 Dec 21
Prospectus supplement
12:06pm
425
EX-99.1
84ns899mkqrgjkp 2ys7
18 Nov 21
Business combination disclosure
9:14am
8-K
EX-99.1
tpn0yvk lfv
18 Nov 21
Regulation FD Disclosure
9:02am
S-4/A
c2kietzl7722sj
14 Sep 21
Registration of securities issued in business combination transactions (amended)
6:45am
S-4
kn4qsmmxc3jl304
4 Aug 21
Registration of securities issued in business combination transactions
3:02pm